MCIA welcomes new Parliamentary Friends of Medicinal Cannabis Group

Medicinal Cannabis Industry Australia (MCIA) is delighted to welcome the establishment of a Parliamentary Friends of Medicinal Cannabis Group in the Federal Parliament.

The group will provide a non-partisan forum for Members and Senators to meet with representatives of the Australian medicinal cannabis industry, medical experts and patient advocates to raise awareness of the applications of medicinal cannabis to Parliamentarians and within the broader community.

“The Australian government made medicinal cannabis legal in 2016 and established a regulatory framework through the Therapeutic Goods Administration (TGA) and Office of Drug Control (ODC) to ensure products for Australian patients are safe and effective,” said MCIA Chairman Peter Crock.

“This Group is an important forum for parliamentarians to learn about the benefits of medicinal cannabis and to further the growth of this important industry that has potential to positively contribute to health and economic outcomes for the community”.

MCIA welcomes the establishment of the Parliamentary Friends of Medicinal Cannabis Group and believes that it will play an important role in improving education and public awareness of medicinal cannabis across the community. “Improving the awareness and understanding of medicinal cannabis will help promote change in attitudes to medicinal cannabis, particularly amongst healthcare practitioners” said Mr Crock.

The Australian licensed sector will have significant capacity coming online over the next couple of years. This should see Australian patients being able to access Australian quality product in a timely and affordable manner. To achieve the shared outcomes of a sustainable industry that contributes to patient wellbeing and the economy, further progress in streamlining regulation, investment in education and providing patient subsidies is required. Mr Crock said “MCIA looks forward to the opportunity to engaging with this Group for the benefit of all Australians.”

The Parliamentary Friends of Medicinal Cannabis Group will be co-convened by two parliamentarians with medical backgrounds: Dr Mike Freelander MP and Dr Andrew Laming MP.

“This group ensures the Federal Parliament keeps a singular focus in facilitating the medicinal cannabis sector,” said Dr Laming MP.

“I look forward to engaging with parliamentary colleagues and health professionals to increase awareness of medicinal cannabis to Australians,” said Dr Laming.

“It is fantastic to see that we now have such broad support for medicinal cannabis in the Commonwealth Parliament,” said Dr Mike Freelander MP.

“We need to have a bipartisan approach for funding for research into the applications for medicinal cannabis and its efficacy in many conditions such as epilepsy, cancer medicine and neurological disorders.”

“This group will serve as a vessel to raise awareness about the applications and benefits of medicinal cannabis in our society,” said Dr Freelander.

More than 30 parliamentarians (below) have expressed an active interest in supporting the group. It is anticipated that the first event to be held for the group will be later in the parliamentary sitting year (COVID- 19 conditions permitting.)

— END —

Download the PDF version of this Media Release

Media Contact:

Medicinal Cannabis Industry Australia
Rosemary Richards
Executive Manager
+61 411 564 128

Peter Crock
+61 419 307 467

About MCIA

MCIA is the peak industry organisation for Australia’s licensed medicinal cannabis industry. This encompasses all activities of medicinal cannabis licence holders across research, cultivation and manufacturing and interaction with patients, the medical profession and communities.

MCIA’s focus is on building an industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients.

MCIA is providing stewardship for an economically sustainable and socially responsible industry that is trusted and valued by patients, the medical community and governments. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products.

Parliamentary Friends of Medicinal Cannabis of the 46th Parliament

Dr Mike FreelanderMacarthur – Co-convenor
Dr Andrew Laming MPBowman – Co-convenor
Hon Sharon Bird MPCunningham
Josh Burns MPMacnamara
Senator Carol BrownTasmania
Senator Catryna BilykTasmania
Brian Mitchell MPLyons
Hon Joel FitzgibbonLeichardt
MP Hon Warren EntschHunter
MP Hon Dr John McVeighGroom
Hon Dr Andrew LeighFenner
Ross Vasta MPBonner
Ted O’Brien MPFairfax
Hon David Gillespie MPLyne
Hon Warren Snowdon MPLingiari
Senator Anne UrquhartTasmania
George Christensen MPDawson
Senator Malcolm RobertsQueensland
Steve Georganas MPAdelaide
Senator Helen PolleyTasmania
Luke Gosling OAM MPSolomon
Hon Chris Bowen MPMcMahon
Susan Templeman MPMacquarie
Michelle Landry MPCapricornia
Dr Helen Haines MPIndi
Maria Vamvakinou MPCalwell
Hon Damien Drum MPNicholls
Senator Louise PrattWestern Australia
Senator the Hon Richard ColbeckTasmania
Parliamentary Friends of Medicinal Cannabis 20 July 2020